Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 6/20 | 0.46 |
| ▸ | FLT3 | P36888 | 1/20 | 0.30 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.30 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20164616 | 0.86 | SLC29A1 (0.46) | SLC29A1TLR7APPBCHEACHE | |
| SCHEMBL20164624 | 0.85 | SLC29A1 (0.44) | SLC29A1TLR7APPBCHEACHE | |
| SCHEMBL20164310 | 0.85 | SLC29A1 (0.44) | SLC29A1TLR7APPBCHEACHE | |
| SCHEMBL20164496 | 0.85 | SLC29A1 (0.44) | SLC29A1TLR7APPBCHEACHE | |
| SCHEMBL31400311 | 0.85 | SLC29A1 (0.43) | SLC29A1TLR7APPBCHEACHE | |
| Hydrochloric Acid SCHEMBL20164444 | 0.84 | SLC29A1 (0.44) | SLC29A1 | |
| Hydrochloric Acid SCHEMBL20164585 | 0.84 | SLC29A1 (0.43) | SLC29A1TLR7APPBCHEACHE | |
| Hydrochloric Acid SCHEMBL20164674 | 0.84 | SLC29A1 (0.43) | SLC29A1TLR7APPBCHEACHE | |
| Hydrochloric Acid SCHEMBL20164587 | 0.84 | SLC29A1 (0.43) | SLC29A1TLR7APPBCHEACHE | |
| SCHEMBL20164456 | 0.83 | SLC29A1 (0.46) | SLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10294228-B2 | Breathing control modulating compounds, and methods of making and using same | NEURAD LTD. (IL) | 2019-05-21 | — | — | US | disclosed |
| US-20180141953-A1 | Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same | NEURAD LTD. (IL) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180141953-A1 | Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same | MTNR1B, CHRM3, PER2 | SLC29A1 4472/4885FLT3 4814/4885TLR7 4569/4885 |
| US-10294228-B2 | Breathing control modulating compounds, and methods of making and using same | MTNR1B, PDE3A, CHRM3 | SLC29A1 4518/4885FLT3 4789/4885TLR7 4584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.